- Target Boycott Shouldn't Worry Investors: It Won't Hurt Sales; Target Responds
- Sarepta Can Win Speedy FDA Drug Approval
- 10 Countries Where That Social Security Check Will Let You Retire in Style
- 10 Fuel-Efficient Cars For Your Volkswagen Diesel Buyback Money
- Retirees Are Opting to Rent Homes Likes Millennials
The iconic restaurant chain is focusing more on better quality food and local tastes.
A U.S. District Court judge ruled that the struggling social media had failed to provide enough cause for its lawsuit, although she is allowing Twitter to refile the case.
Apple has suffered from sluggish iPhone sales and a slowing Chinese economy, but it produces innovative, aesthetically pleasing products that are likely to remain in demand.
If Alibaba beats on both the top and the bottom lines, the stock could reclaim its April 20 high of $81. Here's how to trade it.
Stock futures on Wednesday point to an extension of Tuesday's losses after an unofficial reading on the labor market misses estimates by a wide mark.
Donald Trump has had a lot of success in business, but how would he be for the economy as president? Here's how his economic policies would play out.
Pfizer (PFE) has reportedly approached San Francisco based cancer drug maker Medivation (MDVN) about a buyout.
Here are Wednesday's top research calls, including upgrades for AstraZeneca, Dollar General and FedEx, and a pair of downgrades for Anadarko Petroleum.
Here's how to use technical charts to trade health insurance companies Aetna, Anthem, Cigna, Centene and UnitedHealth.
Brazilian prosecutors want $44 billion to pay for compensation and restoration following last year's Samarco dam collapse.
Imperial Brands leaves investors cautious on the stock despite strong growth in adjusted earnings.
Wall Street appears to care about two things from Whole Foods - sales and profits.
Time Warner shares rise in premarket trading as the New York-based media company reports earnings that beat analysts' estimates on improved performance at its Turner television group.
Europe's highest court upholds a ban on fancy packaging and other marketing ploys.
Voracious and efficient, Gannett was anathema to journalists of a previous generation. But for Tribune's editors and reporters, the company may look more like a savior.